Merck & Co., Inc. (NYSE: MRK) reported stronger than expected earnings and sales for the third quarter of 2020. The company's stock
Infographic: Highlights of Merck & Co. (MRK) Q3 2020 earnings report
Categories
Biotechnology
Biogen Inc. (BIIB) Q3 2020 Earnings Call Transcript
Biogen Inc. (NASDAQ: BIIB) Q3 2020 earnings call dated Oct. 21, 2020 Corporate Participants: Joe Mara -- Head of Investor Relations Michel Vounatsos -- Chief Executive Officer
Biogen tops market estimates in Q3, lowers guidance
Biogen (NASDAQ: BIIB) reported third-quarter 2020 financial results before the opening bell on Wednesday. The biotechnology giant reported a 6% decline in
AstraZeneca stock looks a good bet as COVID antibody drug brings fresh hope
With the pandemic situation showing little signs of improvement, healthcare institutions are under pressure to expedite their vaccine development programs, amid growing
OXFORD BIOMEDICA PLC (OXB) Q2 2020 Earnings Call Transcript
OXFORD BIOMEDICA PLC (OTC: OXB) Q2 2020 earnings call dated Sep. 17, 2020 Corporate Participants: Catherine Isted -- Head of Corporate Development
Auris Medical Holding AG (EARS) Q2 2020 Earnings Call Transcript
Auris Medical Holding AG (NASDAQ: EARS) Q2 2020 earnings call dated Sep. 17, 2020. Corporate Participants: Thomas Meyer -- Chief Executive Officer
Applied Genetic Technologies Corp. (AGTC) Q4 2020 Earnings Call Transcript
Applied Genetic Technologies Corp. (NASDAQ: AGTC) Q4 2020 earnings call dated Sep. 09, 2020 Corporate Participants: Sue Washer -- President and Chief Executive Officer
Ascendis Pharma A/S (ASND) Q2 2020 Earnings Call Transcript
Ascendis Pharma A/S (NASDAQ: ASND) Q2 2020 earnings call dated Aug. 27, 2020 Corporate Participants: Scott T. Smith -- Senior Vice President and Chief
Palatin Technologies Inc. (PTN) Q4 2020 Earnings Call Transcript
Palatin Technologies Inc (NYSEAMERICAN : PTN) Q4 2020 earnings call dated Sep. 28, 2020 Corporate Participants: Carl Spana -- President and Chief Executive Officer
What makes CVS Health a better investment option than Walgreens
https://www.youtube.com/watch?v=WOSh4S0zUds For healthcare systems across the world, currently, the first priority is to find an effective treatment for coronavirus, at a time
AnPac Bio-Medical Science Co., Ltd (ANPC) Q2 2020 Earnings Call Transcript
AnPac Bio-Medical Science Co., Ltd (NASDAQ: ANPC) earnings call dated September 10, 2020 Corporate Participants: Phil Case -- Marketing and Investor Relations Chris Yu -- Co-Founder
BeyondSpring Inc. (BYSI) Q2 2020 Earnings Call Transcript
BeyondSpring Inc. (NASDAQ: BYSI) Q2 2020 earnings call dated Sep. 03, 2020 Corporate Participants: Scott Eckstein -- Vice President Lan Huang -- Co-Founder, Chairman & Chief
Illumina (ILMN) is uniquely placed to offer long-term returns. Here’s why
Illumina, Inc. (NASDAQ: ILMN), a pioneer in genome sequencing technology, has strived to strengthen its unique position in the healthcare sector through
Silence Therapeutics PLC (SLN) Q2 2020 Earnings Call Transcript
Silence Therapeutics PLC (LON: SLN) Q2 2020 earnings call dated Sep. 14, 2020 Corporate Participants: Gem Hopkins -- Head of Investor Relations and Corporate
Avid Bioservices, Inc. (CDMO) Q1 2021 Earnings Call Transcript
Avid Bioservices, Inc. (NASDAQ: CDMO) Q1 2021 earnings call dated Sep. 01, 2020 Corporate Participants: Tim Brons -- Investor Relations Nicholas Green -- President & Chief
Aimmune Therapeutics Inc (AIMT) Q2 2020 Earnings Call Transcript
Aimmune Therapeutics Inc (NASDAQ: AIMT) Q2 2020 earnings call dated July 30, 2020 Corporate Participants: DeDe Sheel -- Vice President of Investor Relations
Should you buy Liminal BioSciences (LMNL) stock?
So far, COVID-19 has claimed more than 800,000 lives all over the world. The biomedical community is rigorously working on finding an
CureVac (CVAC): Another COVID-19 stock that attracted investors
In recent times, investors have been betting on the biotech companies that are in the race to develop the COVID-19 vaccine. The
Is Altimmune (ALT) stock a buy right now?
A lot of stocks in the biotech space have skyrocketed this year after their announcements and advances in finding a vaccine or
Novavax (NVAX) stock tumbles despite beating bottom line estimates in Q2
After Novavax (NASDAQ: NVAX) reported its progress on developing the COVID-19 vaccine at the end of February, the shares of the company
Aurinia Pharmaceuticals Inc. (AUPH) Q2 2020 Earnings Call Transcript
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) Q2 2020 earnings call dated Aug. 11, 2020 Corporate Participants: Glenn Schulman -- Senior Vice President, Corporate Communications and